Headache
📧 Sign up to get email alerts when something new happens for Headache.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-05-08FDA Approved: IBUPROFEN — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's ibuprofen generic under Original Application (ANDA213794). The product is a generic version of ibupr…
-
CLINICAL_TRIALS trial_result · 2020-03-27Clinical Trial Update: A Study Investigating the Efficacy of GON Blocks. [Phase 4]
A Phase 4 clinical trial investigating the efficacy of GON Blocks completed, with results pending or not specified in the snippet.
-
CLINICAL_TRIALS trial_result · 2020-02-21Clinical Trial Update: Dexmedetomidine and Propofol for Pediatric MRI Sedation [Phase 4]
Phase 4 trial assessing Dexmedetomidine and Propofol for pediatric MRI sedation has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Treatment of Post-dural Puncture Headache in Postpartum Patients: Sphenopalatine Ganglion Block to Epidural Blood Patch. [Phase 4]
Phase 4 trial comparing sphenopalatine ganglion block to epidural blood patch for post-dural puncture headache in postpartum patients; trial…
-
CLINICAL_TRIALS trial_result · 2019-12-24Clinical Trial Update: HIRREM Developmental Study [NA]
Clinical trial update for the HIRREM developmental study; the study is completed with results posted in 2019.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea [Phase 2]
Phase 2 clinical trial exploring sublingual tablets with cannabinoid combinations for dysmenorrhea and related symptoms.
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Olanzapine for Acute Headaches [Phase 4]
Phase 4 trial update on olanzapine for acute headaches has completed with results posted.
-
FDA approval · 2019-07-22FDA Approved: IBUPROFEN — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for ibuprofen from Chartwell RX, LLC under ANDA 202413, authorizing the specified changes to thi…
-
FDA approval · 2019-07-22FDA Approved: IBUPROFEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for ibuprofen by Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: Ticagrelor Therapy for RefrACTORy Migraine Study [Phase 4]
Phase 4 trial update on ticagrelor therapy for refractory migraine completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: rTMS Treatment of Persistent Headache and Post Concussion Symptoms Attributed to Mild Traumatic Injury to the Head [Phase 1, Phase 2]
Clinical trial updates on rTMS for persistent headache and post-concussion symptoms following mild traumatic brain injury have completed Pha…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Evaluation of an Integrated Care Project
Completed clinical trial update from Charite University on an integrated care project addressing asthma, allergic rhinitis, atopic eczema, m…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: The Effect of PACAP27 on the Extra- and Intracerebral Arteries Assessed by Magnetic Resonance Angiography (MRA) on Healthy Volunteers [NA]
A completed clinical trial evaluating the effect of PACAP27 on extra- and intracerebral arteries in healthy volunteers using magnetic resona…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: The Effect of Intravenous L-kynurenine (LKYN) on Cerebral Hemodynamics in Healthy Volunteers [Phase 1]
Phase 1 study investigating the effect of intravenous L-kynurenine (LKYN) on cerebral hemodynamics in healthy volunteers has completed.
-
FDA approval · 2018-12-28FDA Approved: BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE — Supplemental Application (LGM PHARMA SOLUTIONS, LLC)
The FDA approved a supplemental application for the generic combination product butalbital, acetaminophen, and caffeine from LGM PHARMA SOLU…
-
CLINICAL_TRIALS trial_result · 2018-12-20Clinical Trial Update: Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females [Phase 1]
Phase 1 study evaluating drug interaction between erenumab (AMG 334) and combined oral contraceptive in healthy females; completed with resu…
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Efficacy of a Single Dose of Aspirin vs. Acetaminophen in Tension Type Headache [Phase 3]
Phase 3 trial comparing a single dose of aspirin to acetaminophen for tension-type headache was terminated.
-
FDA approval · 2018-10-31FDA Approved: BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE — Original Application (LGM PHARMA SOLUTIONS, LLC)
FDA approved a generic version of the combination analgesic butalbital, acetaminophen, and caffeine for headache indications.
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: Efficacy of Haloperidol vs. Metoclopramide for Treatment of Acute Headaches and Migraines in the Emergency Department [Phase 4]
Phase 4 trial comparing haloperidol to metoclopramide for acute headache/migraine in the emergency department was terminated with results po…
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Internet Intervention for Adolescents With Chronic Pain [Phase 2]
A Phase 2 clinical trial evaluating an internet intervention for adolescents with chronic pain has completed.
-
FDA approval · 2018-09-26FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Original Application (Aurolife Pharma, LLC)
FDA approved a generic tablet containing butalbital, acetaminophen, and caffeine under ANDA204733 (Original Application) for Aurolife Pharma…
-
CLINICAL_TRIALS research · 2018-07-05Clinical Trial Update: Influence of Main Psychological and Social Factors on Primary Headaches
This clinical trial update reports on research into how major psychological and social factors influence primary headaches, including migrai…
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Headache Inducing Effect of Cromakalim in Migraine Patients [NA]
A completed trial evaluating cromakalim in migraine patients observed a headache-inducing effect, signaling a potential safety risk.
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: A Cost Effective Treatment for Headache in Pregnancy When Acetaminophen Alone is Ineffective. [NA]
A completed clinical trial evaluated a cost-effective treatment for headaches during pregnancy when acetaminophen alone is ineffective; resu…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain [NA]
The GET Living graded exposure treatment trial for children and adolescents with chronic pain has completed, according to Boston Children's …